Accounts Payable Trade Current Trade payables Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities Accrued expenses and other liabilities Discloses the breakout of accrued expenses and other liabilities that are not individually material for a separate caption on the statement of financial position between the current portion (payable within 12 months of year end or the operating cycle) and non-current (payable after 12 months from year end). Accrued Expenses And Other Liabilities Disclosure [Text Block] ACCRUED EXPENSES AND OTHER LIABILITIES Accrued Severance, Noncurrent Accrued Severance Noncurrent Liability in Respect of Employees Severance Payments Additional Paid In Capital Additional paid-in capital Additional Paid In Capital [Member] Additional paid-in capital Adjustments To Additional Paid In Capital Other Contributed profit from shareholder's transactions Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Stock-based compensation Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net (loss) to net cash (used in) operating activities: All Other [Member] All Other [Member] All Other Amendment Flag Amendment Flag Amortization of Deferred Stock Based Compensation Amortization Deferred Stock Based Compensation Amortization of deferred compensation on restricted shares of common stock to non employees Assets Total Assets Assets [Abstract] ASSETS Assets Current Total Current Assets Assets Current [Abstract] Current Assets: Assets Noncurrent Total Long Term Assets Assets Noncurrent [Abstract] Long Term Assets: Basis Of Presentation And Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES Capital contributed by affiliate. Capital Contributed Contributed capital Capital Contributed Shares Capital Contributed Shares Contributed capital (in shares) Capital Stock [Abstract] Capital Stock [Abstract] Stock capital - Cash And Cash Equivalents At Carrying Value Cash and cash equivalents at the end of the period Cash and cash equivalents at the beginning of the period Cash and cash equivalents Cash And Cash Equivalents Period Increase Decrease Increase (decrease) in cash and cash equivalents Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Non cash transactions: Commitments And Contingencies Commitments and Contingent Liabilities Commitments And Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENT LIABILITIES Common Shares Acquired For Cashless Exercise Of Warrants Common Shares Acquired For Cashless Exercise Of Warrants Cashless exercise, stock warrants Common Stock Issued In Exercise Of Employee Stock Option Common Stock Issued In Exercise Of Employee Stock Option Employee options exercised to shares of common stock Common Stock [Member] Common Stock Common Stock Par Or Stated Value Per Share Common shares, par value Common Stock Shares Authorized Common stock, authorized Common Stock Shares Issued Common shares, shares issued Common Stock Shares Outstanding Common shares, shares outstanding Common Stock Value Common shares of $ 0.00001 par value per share 300,000,000 shares of common stock authorized; 54,565,358 and 54,116,628 shares issued and outstanding on December 31, 2011 and 2010, respectively Conversion Of Stock Amount Converted 1 Conversion of preferred stock to common stock Costs And Expenses [Abstract] Operating expenses: Current Assets [Member] Current Assets [Member] Short term deposit Current Fiscal Year End Date Current Fiscal Year End Date Deferred Compensation Share Based Payments [Member] Deferred compensation Deposits Assets Current Short term deposits Deposits Assets Noncurrent Long term deposits Depreciation Depreciation Development Stage Enterprise Deficit Accumulated During Development Stage (Deficit) accumulated during the development stage Development Stage Enterprise, Deficit Accumulated During Development Stage Development Stage Enterprise Deficit Accumulated During Development Stage [Member] (Deficit)accumulated during the development stage Document - Document and Entity Information [Abstract] Document Documentand Entity Information [Abstract] Document - Document and Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Information [Line Items] Document Information [Line Items] Document Period End Date Document Period End Date Document Type Document Type Due To Related Parties Current Related parties payable Earnings Per Share Basic And Diluted (Loss) per share (basic & diluted) Entities [Table] Entities [Table] Entity Central Index Key Entity Central Index Key Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Current Reporting Status Entity [Domain] Entity [Domain] Entity Filer Category Entity Filer Category Entity Public Float Entity Public Float Entity Registrant Name Entity Registrant Name Entity Voluntary Filers Entity Voluntary Filers Entity Well Known Seasoned Issuer Entity Well-known Seasoned Issuer Equity Component [Domain] Equity Component [Domain] Foreign Currency Transaction Gain Loss Unrealized Long term deposit exchange rate differences General And Administrative Expense General and administrative General And Administrative Expenses [Text Block] General And Administrative Expenses [Text Block] GENERAL AND ADMINISTRATIVE EXPENSES Income Statement [Abstract] Income Statement [Abstract] Income Tax Disclosure [Text Block] INCOME TAXES Income Taxes Paid Cash paid for income taxes Increase Decrease In Accounts Payable Trade Increase (decrease) in trade payables Increase Decrease In Accounts Receivable And Other Operating Assets Decrease (increase) in accounts receivable and prepaid expenses Increase Decrease In Accrued Liabilities And Other Operating Liabilities Increase in accrued expenses and other liabilities Increase Decrease In Due To Related Parties Current Increase in related parties payable Increase Decrease In Restricted Cash Restricted cash Interest Income Expense Net Financial (expenses) income, net Interest Paid Cash paid for interest expense Issuance of Common Shares for Cashless Exercise of Warrants Issuance Of Common Shares For Cashless Exercise Of Warrants Cashless exercise, shares of common stock Legal Entity [Axis] Legal Entity [Axis] Liabilities And Stockholders Equity Total Liabilities and Stockholders' Equity Liabilities And Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Current Total Current Liabilities Liabilities Current [Abstract] Current Liabilities: Loans Assumed 1 Loan granted by the Company to Prolor Ltd. Loans Notes Trade And Other Receivables Disclosure [Text Block] ACCOUNTS RECEIVABLE AND PREPAID EXPENSES Nature Of Operations GENERAL Net Cash Provided By Used In Financing Activities Net cash provided by financing activities Net Cash Provided By Used In Financing Activities [Abstract] Cash flows from financing activities Net Cash Provided By Used In Investing Activities Net cash provided by (used in) investing activities Net Cash Provided By Used In Investing Activities [Abstract] Cash flows from investing activities Net Cash Provided By Used In Operating Activities Net cash (used in) operating activities Net Cash Provided By Used In Operating Activities [Abstract] Cash flows from operating activities Net Income Loss Net (loss) Net (loss) New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets Cumulative effect of first time adoption of the fair value based method for stock-based compensation to employees Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed 1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed), Total Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed [Abstract] Payment for the acquisition of Prolor Ltd.: Noncash Or Part Noncash Acquisition Other Assets Acquired 1 Cash at date of acquisition in Prolor Ltd. Noncurrent Assets [Member] Noncurrent Assets [Member] Long term deposit Non Employee Stock Options[Member] Non Employee Stock Options [Member] options granted to non employees Notes to Financial Statements [Abstract] Notes To Financial Statements [Abstract] Notes to Financial Statements [Abstract] Operating Income Loss Operating (loss) Option [Member] Options Other Income And Other Expense Disclosure [Text Block] -FINANCIAL (EXPENSES) INCOME, NET Payments For Proceeds From Other Deposits Proceeds from (Payments) Deposits Payments For Proceeds From Other Investing Activities Assets held for employees' severance payments Payments To Acquire Businesses Net Of Cash Acquired Payment for the acquisition of Prolor Ltd. Payments To Acquire Property Plant And Equipment Purchase of property and equipment Preferred Stock [Member] Preferred Stock Preferred Stock Par Or Stated Value Per Share Preferred stock, par value Preferred Stock Shares Authorized Preferred stock, authorized Preferred Stock Shares Issued Preferred stock, shares issued Preferred Stock Shares Outstanding Preferred stock, shares outstanding Preferred Stock Value Preferred stock of $ 0.00001 par value per share 10,000,000 shares of preferred stock authorized; none issued and outstanding on December 31, 2011 and 2010, respectively Prepaid Expense And Other Assets Current Accounts receivable and prepaid expenses Proceeds From Issuance Of Common Stock Proceeds from issuance of shares Proceeds From Issuance Of Debt Principal payment of loans Proceeds From Payments For Other Financing Activities Contributed profit from shareholder's transactions Proceeds From Stock Options Exercised Proceeds from exercise of options Proceeds From Warrant Exercises Proceeds from exercise of warrants Property Plant And Equipment Disclosure [Text Block] PROPERTY AND EQUIPMENT, NET Property Plant And Equipment Net Property and equipment, net Quarterly Financial Information [Text Block] SELECTED QUARTERLY FINANCIAL INFORMATION Related Party Transactions Disclosure [Text Block] CONSULTING AND EMPLOYMENT AGREEMENTS WITH RELATED PARTIES Repayments Of Bank Debt Short term bank credit Repayments Of Debt Proceeds from loans Research And Development Disclosure [Text Block] Research And Development Disclosure [Text Block] RESEARCH AND DEVELOPMENT EXPENSES, NET Research And Development Expense Excluding Acquired In Process Cost Research and development, net Research And Development In Process In-process research and development write-off In-process research and development write-off Restricted Cash And Cash Equivalents At Carrying Value Restricted cash Restricted Cash And Cash Equivalents Noncurrent Restricted cash Revenues Revenues Scenario Unspecified [Domain] Scenario, Unspecified [Domain] Severance Costs Liability in respect of employees severance payments Severance Pay Fund, Noncurrent Severance Pay Fund Noncurrent Assets held for employees' severance payments Share Based Compensation Stock-based compensation Shares Outstanding Ending Balance (in shares) Statement Equity Components [Axis] Statement, Equity Components [Axis] Statement [Line Items] Statement [Line Items] Statement Of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Statement Of Financial Position [Abstract] Statement of Financial Position [Abstract] Statement Of Stockholders Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement Scenario [Axis] Statement, Scenario [Axis] Statement [Table] Statement [Table] Stockholders Equity Ending Balance Beginning Balance Total Stockholders' Equity Stockholders Equity [Abstract] Stockholders' Equity: Stockholders Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY Stock Issued 1 Issuance of common stock in reverse acquisition Stock Issued During Period, Shares Stock Issued During Period Shares Issuance of common stock in reverse acquisition (in shares) Stock Issued During Period Shares Acquisitions Issuance of common stock and options in conjunction with the acquisition of Prolor BioTech Ltd. (in shares) Stock Issued During Period Shares Conversion Of Convertible Securities Conversion of Preferred stock (in shares) Stock Issued During Period Shares New Issues Issuance of stock (in shares) Stock Issued During Period Shares Other Issuance of common stock and options in private placement (in shares) Stock Issued During Period Shares Stock Options Exercised Options exercised (in shares) Number of shares issued during the period as a result of the exercise of warrants. Stock Issued During Period Shares Stock Warrants Exercised Warrants exercised (in shares) Stock Issued During Period Stock Issued During Period Value Issuance of common stock in reverse acquisition Stock Issued During Period Value Acquisitions Issuance of common stock and options in conjunction with the acquisition of Prolor BioTech Ltd. Stock Issued During Period Value Conversion Of Convertible Securities Conversion of Preferred stock Stock Issued During Period Value New Issues Issuance of stock Stock Issued During Period Value Other Issuance of common stock and options in private placement Stock Issued During Period Value Stock Options Exercised Options exercised Value stock issued during the period as a result of the exercise of warrants. Stock Issued During Period Value Stock Warrants Exercised Warrants exercised Stock Issued Share for Restricted Shares Vested Stock Issued Share For Restricted Shares Vested Deferred compensation on restricted shares to non-employees (in shares) Stock Issued Value for Restricted Shares Vested Stock Issued Value For Restricted Shares Vested Deferred compensation on restricted shares to non-employees Subsequent Events [Text Block] - SUBSEQUENT EVENTS Supplemental Cash Flow Information [Abstract] Additional information: Supplemental Exercise Of Warrants To Purchase Common Stock Supplemental Exercise Of Warrants To Purchase Common Stock Cashless exercise of 169,361 and 917,421 outstanding stock warrants to 123,014 and 625,797 shares of common stock Supplemental offering and stock issuance costs Supplemental Offering And Stock Issuance Costs Issuance expenses Trading Symbol Trading Symbol Weighted Average Number of Shares Outstanding where Basic and Diluted are the same and reported as a single line Weighted Average Number Basic Diluted Shares Outstanding Weighted average number of shares outstanding